You will be redirected to https://www.worldscientific.com/apbn to view or purchase the issue PDF.
BioBoard
Australia • New Therapy could Restore Mobility in Stroke Victims • Sugar as Bad as Fat • Scientists Uncover Cancer-fighting "Death" Protein • Shrinking Brain in Dementia Prompts Overeating • New Monitoring System for Mosquito-Borne Disease • Australian Researcher Finds Radical Technique to Save MAS Babies • Austrian Scientists Discover Enzyme Function in Cancer
China • Banned Chemical Found in China Cosmetics • China PharmaHub Corp. Introduces A 'Magic Bullet' Liver Cancer Therapy
India • India, South Africa to Team up on HIV Vaccine Research
Malaysia • Malaysia to use Lab Mosquitoes to Fight Dengue
New Zealand • Plant Derived Foods can Keep us Feeling Full
Singapore • Singapore Hosts First "Decade of the Mind" Conference in Asia and Expands Efforts in Brain & Cognition Research • Drugs May Replace Chemo in Leukemia Therapy • Singapore Scientists First to Perform Genome-Wide study of Human Stem Cells • Singapore Babies in Waste-disease Trial • New Technology a Shot in the Arm for Biofuels • S$3.7 Billion for Singapore Biomedical Sciences R&D
Taiwan • Medical Tourism Booms in Taiwan OTHER REGIONS Europe • Gene that Triggers Human Cancer Identified • Painfully Potent Pepper North America • 2 Dads and No Mum make 10 Mice Feature • Neem: A Wonder Tree • Bacteria Living on Arsenic Discovered • Temsirolimus Approved in Singapore for Advanced Renal Cell Carcinoma • AttuneTM Acoustic Focusing Cytometer • Securing Genetic Diversity of Rice in "Doomsday Vault" • Leica Opens New Dimension in Spectral Imaging Industry Watch • Phylogica Commences Antimicrobial Peptide Discovery under Agreement with MedImmune • Leadtec Systems Australia to Acquire Mimotopes • Sirnaomics Seals Deal for Development of RNAi Therapeutics in China • Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Early-Stage Oncology Compound • Pfizer, Biocon in $350 Million Insulin Pact • Bharat Biotech Announces Launch of "HNVACTM" India's First Cell-Culture H1N1 Swine Flu Vaccine • Cipla Launches the World’s First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) • Eisai and FORMA Therapeutics Enter into Broad Drug Discovery Collaboration • Philips and Atom Medical Corporation Announce Strategic Alliance to Provide a Complete Neonatal and Perinatal Offering • CiRA and France-based Cellectis Enter Collaboration • Immunovaccine Signs Research Agreement with OncoTherapy Science to Advance Potential Cancer Vaccine • Glycos Biotechnologies Enters Definitive Agreement with Malaysian Bio-XCell • Biocon Plans to Invest $161m in Malaysia to Set Up R&D Unit Research and Findings • A*STAR IME Heralds Personalized Therapy for Cancer Patients • Singapore Scientist Leads Team to Discover Origin of Brain Immune Cells People Watch • New Honor for Eminent Cardiac Surgeon Cherian • Austin Researcher a Dual Award Winner • Medals Awarded to Top New Zealand Researchers Conference Calendar
North America • 2 Dads and No Mum make 10 Mice
Feature • Neem: A Wonder Tree • Bacteria Living on Arsenic Discovered • Temsirolimus Approved in Singapore for Advanced Renal Cell Carcinoma • AttuneTM Acoustic Focusing Cytometer • Securing Genetic Diversity of Rice in "Doomsday Vault" • Leica Opens New Dimension in Spectral Imaging
Industry Watch • Phylogica Commences Antimicrobial Peptide Discovery under Agreement with MedImmune • Leadtec Systems Australia to Acquire Mimotopes • Sirnaomics Seals Deal for Development of RNAi Therapeutics in China • Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Early-Stage Oncology Compound • Pfizer, Biocon in $350 Million Insulin Pact • Bharat Biotech Announces Launch of "HNVACTM" India's First Cell-Culture H1N1 Swine Flu Vaccine • Cipla Launches the World’s First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) • Eisai and FORMA Therapeutics Enter into Broad Drug Discovery Collaboration • Philips and Atom Medical Corporation Announce Strategic Alliance to Provide a Complete Neonatal and Perinatal Offering • CiRA and France-based Cellectis Enter Collaboration • Immunovaccine Signs Research Agreement with OncoTherapy Science to Advance Potential Cancer Vaccine • Glycos Biotechnologies Enters Definitive Agreement with Malaysian Bio-XCell • Biocon Plans to Invest $161m in Malaysia to Set Up R&D Unit
Research and Findings • A*STAR IME Heralds Personalized Therapy for Cancer Patients • Singapore Scientist Leads Team to Discover Origin of Brain Immune Cells
People Watch • New Honor for Eminent Cardiac Surgeon Cherian • Austin Researcher a Dual Award Winner • Medals Awarded to Top New Zealand Researchers
Conference Calendar
